Sympathomimetics Flashcards
Constitute a group of drugs used for
Cardiovascular
Respiratory
Other conditions
adrenomimetics
Type of adrenomimetics based on mode of action
Bind to and activate the adrenoceptors
Result to sympathetic stimulation
DIRECT-ACTING SYMPATHOMIMETICS
INDIRECT-ACTING SYMPATHOMIMETICS
Displacement of stored cathecolamines in the synapse
releasers
example of releasers
tyramine, amphetamine
INDIRECT-ACTING SYMPATHOMIMETICS
Inhibit the reuptake of cathecolamines by nerve terminals
Reuptake inhibitors
example of Reuptake inhibitors
Cocaine, tricyclic antidepressants
Constitute a third class of adrenoceptors Drugs mentioned have little effect on dopamine receptors May act as a potent dopamine receptor agonist itself Intermediate doses activate beta receptors Large doses activate alpha receptors
DOPAMINE
dopamine
Intermediate doses activate – receptors
beta
dopamine
Large doses activate –receptors
dopamine
Drug preferentially binds to one subgroup of receptors at concentrations too low to interact with another receptor
RECEPTOR SELECTIVITY
Parent compound of sympathetic drug
phenylethylamine
effect of Increasing the size of alkyl substituents
Enhanced activity for beta 2 receptors
Lowers alpha receptor activity
Methyl substitution on NE yields —-
Effect:
Enhanced activity for beta 2 receptors
epinephrine
Effect: Enhanced activity for beta 2 receptors
Isopropyl substitution on NE yields
isoproterenol
-OH groups at the C? and C? positions yield cathecolamines
c3 and c4
effect of Absence of one or both –OH group
Increases bioavailability after oral administration
COMT resistant
Increase distribution to the CNS
Amphetamine and ephedrine
effect of C. Substitution on the alpha carbon
Add methyl group
MAO resistant
Amphetamine and ephedrine
effect of D. Substitution on the beta carbon
Add OH group
Facilitates activation of adrenoceptors
For storage of cathecolamines
Direct-acting sympathomimetics
Dopamine does not contain beta-OH group
does dopamine contain a beta-OH group
Dopamine does not contain beta-OH group
comparative competency for alpha receptors
E > NE> isoproterenol
receptor responsible for
Increase in phosphatidyl inositol (IP3)
Release of calcium
alpha 1
receptor responsible for decrease cAMP
D1 and alpha 2
comparative competency BETA RECEPTOR ACTIVATION
Isoproterenol > epinephrine > NE
receptors responsible for increase cAMP
B1, B2, B3